In summary, serum PTX3 is potentially a sensitive and specific diagnostic biomarker for PDAC with the ability to separate PDAC from other pancreatic diseases such as IPMN and chronic pancreatitis, which pose frequent diagnostic dilemmas in clinical practice (Supplementary Fig. 8). Here, PTX3 is linked to pancreatic intraductal papillary-mucinous neoplasm.